作者: C. L. Bryce , D. C. Angus , R. M. Arnold , C.-C. H. Chang , M. H. Farrell
DOI: 10.1111/J.1600-6143.2009.02737.X
关键词:
摘要: The question of whether health care inequities occur before patients with end-stage liver disease (ESLD) are waitlisted for transplantation has not previously been assessed. To determine the impact gender, race and insurance on access to transplantation, we linked Pennsylvania sources data regarding adult discharged from nongovernmental hospitals 1994 2001. We followed through 2003 information records five centers responsible 95% transplants in during this period. Using multinomial logistic regressions, estimated probabilities that would undergo transplant evaluation, waitlisting itself. Of 144,507 study, 4361 (3.0%) underwent evaluation. those evaluated, 3071 (70.4%) were waitlisted. waitlisted, 1537 (50.0%) received a transplant. Overall, 57,020 (39.5%) died study Patients less likely if they women, black lacked commercial (p < 0.001 each). Differences more pronounced early stages (evaluation listing) than stage (in which national oversight review occur). For management treatment decisions ESLD be better understood, comprehensive concerning referral listing practices needed.